CDK12 and Integrator-PP2A complex modulates LEO1 phosphorylation for processive transcription elongation
Science Advances · 19.05.2023 · 9 (20)
DOI: 10.1126/sciadv.adf8698 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 19.05.2023. Verfasst von Min Qiu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Province Key Laboratory of Allergy and Immunology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China. Hauptthemen laut MEDLINE: Cyclin-Dependent Kinases, RNA Polymerase II. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Cyclin-dependent kinase 12 (CDK12) interacts with cyclin K to form a functional nuclear kinase that promotes processive transcription elongation through phosphorylation of the C-terminal domain of RNA polymerase II (Pol II). To gain a comprehensive understanding of CDK12's cellular function, we used chemical genetic and phosphoproteomic screening to identify a landscape of nuclear human CDK12 substrates, including regulators of transcription, chromatin organization, and RNA splicing. We further validated LEO1, a subunit of the polymerase-associated factor 1 complex (PAF1C), as a bona fide cellular substrate of CDK12. Acute depletion of LEO1, or substituting LEO1 phosphorylation sites with alanine, attenuated PAF1C association with elongating Pol II and impaired processive transcription elongation. Moreover, we discovered that LEO1 interacts with and is dephosphorylated by the Integrator-PP2A complex (INTAC) and that INTAC depletion promotes the association of PAF1C with Pol II. Together, this study reveals an uncharacterized role for CDK12 and INTAC in regulating LEO1 phosphorylation, providing important insights into gene transcription and its regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Hubei Province Key Laboratory of Allergy and Immunology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China.
- State Key Laboratory of Virology, Frontier Science Center for Immunology and Metabolism, Hubei Province Engineering and Technology Research Center for Fluorinated Pharmaceuticals, School of Pharmaceutical Sciences, Wuha…
- Department of Rheumatology and Immunology, Zhongnan Hospital, Wuhan University, Wuhan 430071, China.
- TaiKang Center for Life and Medical Sciences, TaiKang Medical School, Wuhan University, Wuhan 430071, China.
ORCID-Profile: Min Qiu, Zhinang Yin, Honghong Wang, Lingyu Lei, Conghui Li, Yali Cui, Rong Dai, Peiyuan Yang, Ying Xiang, Qiuzi Li, Zhuang Hu, Hai-Bing Zhou, Pingping Fang, Ruijing Xiao, Kaiwei Liang
Zitieren
APA
Qiu, M., Yin, Z., Wang, H., Lei, L., Li, C., Cui, Y., Dai, R., Yang, P., Xiang, Y., Li, Q., Lv, J., Hu, Z., Chen, M., Zhou, H. B., Fang, P., Xiao, R., & Liang, K. (2023). CDK12 and Integrator-PP2A complex modulates LEO1 phosphorylation for processive transcription elongation. Science Advances, 9(20). https://doi.org/10.1126/sciadv.adf8698
Vancouver
Qiu M, Yin Z, Wang H, Lei L, Li C, Cui Y, et al. CDK12 and Integrator-PP2A complex modulates LEO1 phosphorylation for processive transcription elongation. Science Advances. 2023;9(20). doi:10.1126/sciadv.adf8698
BibTeX
@article{Qiu2023,
author = {Qiu, Min and Yin, Zhinang and Wang, Honghong and Lei, Lingyu and Li, Conghui and Cui, Yali and Dai, Rong and Yang, Peiyuan and Xiang, Ying and Li, Qiuzi and Lv, Junhui and Hu, Zhuang and Chen, Min and Zhou, Hai-Bing and Fang, Pingping and Xiao, Ruijing and Liang, Kaiwei},
title = {CDK12 and Integrator-PP2A complex modulates LEO1 phosphorylation for processive transcription elongation},
journal = {Science Advances},
year = {2023},
volume = {9},
number = {20},
doi = {10.1126/sciadv.adf8698}
}
EUVIMED